Zhongshan Iridocorneal Endothelial Syndrome Study (ICEs)

This is a multi-center study to report the demographic profile, clinical features, and management in patients with Iridocorneal endothelial (ICE) syndrome in China.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Sex eligibility

All sexes

Study type

Observational

Primary location

Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of ICE syndrome;
Those willing to sign the informed consent.

Exclusion criteria

Patients who don't sign the informed consent or abide by the study procedure.

Treatment and study plan

Primary outcomes

Management in patients with Iridocorneal endothelial (ICE) syndrome

Time frame: through study completion, an average of 1 year

Record the number of medication treating corneal edema or glaucoma, and surgery (anti-glaucoma surgery, keratoplasty)

Secondary outcomes

Demographic profile of patients

Time frame: 1 day

Range of age, gender

Sponsors and collaborators

Lead sponsor

Sun Yat-sen University

Other

Collaborators

ICE study group

Registry information

Official study title

A Multi-center Study on Iridocorneal Endothelial (ICE) Syndrome in China

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: Sep 1, 2017
Registry last updated: Jun 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed